"Aminopterin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A folic acid derivative used as a rodenticide that has been shown to be teratogenic.
| Descriptor ID |
D000630
|
| MeSH Number(s) |
D03.633.100.733.631.192
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aminopterin".
Below are MeSH descriptors whose meaning is more specific than "Aminopterin".
This graph shows the total number of publications written about "Aminopterin" by people in this website by year, and whether "Aminopterin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aminopterin" by people in Profiles.
-
A Novel Treatment for Glomerular Disease: Targeting the Activated Macrophage Folate Receptor with a Trojan Horse Therapy in Rats. Cells. 2021 08 17; 10(8).
-
Results from a Phase I/II Open-Label, Dose-Finding Study of Pralatrexate and Oral Bexarotene in Patients with Relapsed/Refractory Cutaneous T-cell Lymphoma. Clin Cancer Res. 2017 Jul 15; 23(14):3552-3556.
-
The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma. Br J Haematol. 2017 03; 176(5):750-758.
-
Choosing a systemic treatment for advanced stage cutaneous T-cell lymphoma: mycosis fungoides and S?zary syndrome. Hematology Am Soc Hematol Educ Program. 2015; 2015:529-44.
-
Pralatrexate alone or in combination with bexarotene: long-term tolerability in relapsed/refractory mycosis fungoides. Clin Lymphoma Myeloma Leuk. 2014 Aug; 14(4):297-304.
-
Identification of an active, well-tolerated dose of pralatrexate in patients with relapsed or refractory cutaneous T-cell lymphoma. Blood. 2012 May 03; 119(18):4115-22.
-
An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies. J Immunol Methods. 2008 Jul 31; 336(2):142-51.
-
CD4+ CD56+ hematodermic/plasmacytoid dendritic cell tumor with response to pralatrexate. J Am Acad Dermatol. 2008 Mar; 58(3):480-4.
-
Phase II trial of 10-EDAM in the treatment of metastatic breast cancer. Cancer Chemother Pharmacol. 2007 Jun; 60(1):61-7.
-
Co-administration of probenecid, an inhibitor of a cMOAT/MRP-like plasma membrane ATPase, greatly enhanced the efficacy of a new 10-deazaaminopterin against human solid tumors in vivo. Clin Cancer Res. 2000 Sep; 6(9):3705-12.